Veradigm Inc
OTC:MDRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (8.6), the stock would be worth $9.42 (117% upside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4 | $4.35 |
0%
|
| 3-Year Average | 8.6 | $9.42 |
+117%
|
| 5-Year Average | 5 | $5.46 |
+26%
|
| Industry Average | 16.1 | $17.5 |
+302%
|
| Country Average | 13.3 | $14.53 |
+234%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Veradigm Inc
OTC:MDRX
|
461.4m USD | 4 | -5.3 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 81.5 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 18.4 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.4B USD | 18.7 | 29.1 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.5B AUD | 111.4 | 60.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 15.9 | 20.7 | |
| SE |
|
Sectra AB
STO:SECT B
|
50.6B SEK | 63.3 | 94.2 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 15.4 | 42.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 14.6 | 19.2 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 64.1 | -328 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.7B CNY | 37.4 | -60.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 13.3 |
| 70th Percentile | 20.1 |
| Max | 3 188 432.5 |
Other Multiples
Veradigm Inc
Glance View
Veradigm Inc., formerly known as Allscripts Healthcare Solutions, has carved out a distinct niche within the healthcare technology landscape. The company focuses on the dynamic intersection of technology and healthcare, developing an array of solutions aimed at enhancing healthcare delivery and efficiency. Essentially, Veradigm equips medical professionals with tools for electronic health records, practice management, and remote patient monitoring. By leveraging sophisticated information systems, Veradigm helps streamline operations in doctor's offices, hospitals, and healthcare organizations, making it easier for healthcare providers to deliver efficient and effective services. Their products are designed not only to improve clinical workflows but also to enhance patient engagement, ultimately leading to better health outcomes. The revenue model of Veradigm hinges largely on contractual agreements and subscriptions for its software solutions. By offering a range of cloud-based services, the company ensures a steady flow of recurrent income while reducing the need for expensive on-site installations, thus delivering value to both large hospital systems and smaller, private practices. Additionally, Veradigm has diversified its revenue streams through collaborations with pharmaceutical companies, providing data insights and support for research and marketing initiatives. With a persistent focus on innovation and adaptability, Veradigm not only strengthens its foundational business in healthcare IT but also taps into new opportunities within the emerging landscape of digital health and data analytics.